1.
Br J Haematol
; 196(1): 248-254, 2022 01.
Article
in English
| MEDLINE
| ID: mdl-34435355
Subject(s)
Biomarkers , Histiocytosis, Langerhans-Cell/cerebrospinal fluid , Histiocytosis, Langerhans-Cell/drug therapy , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Neurofilament Proteins/cerebrospinal fluid , Protein Kinase Inhibitors/therapeutic use , Child, Preschool , Disease Susceptibility , Female , Histiocytosis, Langerhans-Cell/diagnosis , Histiocytosis, Langerhans-Cell/etiology , Humans , Infant , Male , Mutation , Prognosis , Protein Kinase Inhibitors/pharmacology , Treatment Outcome
2.
Int J Epidemiol
; 47(1): 22-23u, 2018 02 01.
Article
in English
| MEDLINE
| ID: mdl-29025028